People, Product and Agency News from the Nov. 5 MM&M News Brief
Novartis wins an additional approval for Femara, Lilly acquires the marketing rights to an insomnia drug and the latest personnel ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.